by The infection results in pain, swelling, and tenderness of the salivary glands. The growing prevalence of autoimmune disorders such as Sjögren’s syndrome, HIV/AIDS, autoimmune lymphoproliferative syndrome and graft-versus-host disease which elevates the risk of developing bacterial sialadenitis is driving the growth of the global bacterial sialadenitis market.
The global bacterial sialadenitis market is estimated to be valued at US$ 2.19 Mn in 2024 and is expected to exhibit a CAGR of 6.6% over the forecast period 2024 to 2030.
Key Takeaways
Key players operating in the bacterial sialadenitis market are Schneider Electric, Eaton, Emerson Electric, Toshiba, Siemens, General Electric, Delta Electronics, Huawei, ABB, Vertiv. The market players are seen focusing on new product launches and strategic collaborations to strengthen their market position. For instance, in 2022, General Electric launched the GE Digital Energy Switchgear Monitoring System to provide a comprehensive solution for medium voltage electrical infrastructure monitoring.
The major opportunities in the bacterial sialadenitis market include increasing research and development activities in biological therapies and drugs for the treatment of bacterial sialadenitis. Many companies are exploring the potential of monoclonal antibodies and gene therapies which can help reduce recurrence rates and improve clinical outcomes. The growing demand from emerging economies of Asia Pacific and Latin America owing to increasing healthcare expenditure is also pushing the players to expand their geographic footprint in these untapped markets.
Market drivers
The rising prevalence of autoimmune disorders is a key factor driving the growth of the bacterial sialadenitis market. According to the National Institutes of Health (NIH), around 50 million Americans suffer from some form of autoimmune disease, and the number of people with autoimmune disease is growing globally. Autoimmune diseases like Sjögren’s syndrome, HIV/AIDS, autoimmune lymphoproliferative syndrome elevate the risk of developing bacterial infections of the salivary gland. This significant patient pool suffering from such risk factors is expected to propel the demand for effective diagnostic and treatment options for bacterial sialadenitis over the forecast period.
PEST Analysis
Political: The government regulations regarding diagnostics and treatments would impact the market. New diagnostic guidelines and reimbursement policies can boost or restraint the market.
Economic: Rise in disposable incomes allow people to spend more on healthcare. Economic slowdowns may reduce discretionary healthcare spending and thus restrain the market growth.
Social: Improving awareness about Bacterial Sialadenitis Market Size diagnosis and treatments would drive the market demand. Growing social emphasis on timely diagnosis and management of chronic diseases propel the market growth.
Technological: Advancements in diagnostic imaging technologies aid early and accurate detection. Development of novel treatment drugs and methods help expand the market scope.
Geographical regions of concentration
North America region holds the major share of the global bacterial sialadenitis market in terms of value, because of developed healthcare infrastructure, high awareness, and supportive reimbursement policies in the region. The United States contributes significantly to the North American as well as global market.
Fastest growing region
Asia Pacific region is projected to be the fastest growing market for bacterial sialadenitis during the forecast period. This is attributed to rising medical tourists, increasing healthcare expenditures, growing awareness, and rapidly improving healthcare infrastructure across developing countries in the region. Moreover, growing penetration of global market players would also boost the Asia Pacific market in the coming years.
Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
